Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05523154 · ClinicalTrials.gov registry record · NA
"Answers in Hours" A Randomized Controlled Trial Using Microbiome Metagenomics for Bile Duct Cultures
A NA study, sponsored by Mayo Clinic.
- Terminated
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT05523154: Clinical Trial NA study, sponsored by Mayo Clinic.
NCT05523154 is a NA study that was terminated before completion, run by Mayo Clinic. The registered enrollment target is 8 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05523154, a NA study, was terminated before completion, sponsored by Mayo Clinic.
- TERMINATED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
This trial evaluates whether testing of bile with nanopore sequencing results in earlier detection of bacteriobilia (bacteria in bile) that may lead to surgical site infections in patients undergoing surgery for benign or malignant pancreatic tumors. Surgical site infections are a significant source of poor outcomes in patients undergoing surgery for pancreatic tumors. In most patients who develop this kind of infection, the bacteria identified as causing the infection is also frequently found to be in the bile at time of surgery. Usage of nanopore sequencing for detection of bacteria in the bile of patients undergoing surgery may allow doctors to prevent surgical site infections or treat them sooner or more effectively.
Interventions
- PROCEDURE Biospecimen Collection
- OTHER Laboratory Procedure
- DEVICE Nanopore Sequencing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2023-01-19 |
| Est. Completion | 2023-11-27 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05523154
The ClinicalTrials.gov registry entry for NCT05523154 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Biospecimen Collection is the first listed.
NCT05523154 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05523154 about?
NCT05523154 is a clinical study titled ""Answers in Hours" A Randomized Controlled Trial Using Microbiome Metagenomics for Bile Duct Cultures". This trial evaluates whether testing of bile with nanopore sequencing results in earlier detection of bacteriobilia (bacteria in bile) that may lead to surgical site infections in patients undergoing surgery for benign or malignant pancreatic tumors. Surgical site infections are a significant source...
What is the current status of trial NCT05523154?
This trial is currently terminated. It is a NA study. The enrollment target is 8 participants. The study started on 2023-01-19. Estimated completion is 2023-11-27.
What interventions are being tested in trial NCT05523154?
The interventions under investigation include: Biospecimen Collection (PROCEDURE), Laboratory Procedure (OTHER), Nanopore Sequencing (DEVICE).
Who is sponsoring clinical trial NCT05523154?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.